Charles Schwab Investment Management Inc Inmune Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 34,666 shares of INMB stock, worth $297,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,666
Previous 33,990
1.99%
Holding current value
$297,780
Previous $183,000
12.02%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INMB
# of Institutions
78Shares Held
7.04MCall Options Held
202KPut Options Held
42.9K-
Black Rock Inc. New York, NY813KShares$6.98 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$6.98 Million1.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA738KShares$6.34 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$5.12 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$4.08 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $154M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...